Point-of-care diagnostic that detects Pseudomonas aeruginosa in blood, plasma, urine and saliva using unique microbe-produced biomarkers. Targets respiratory chronic-disease patients (e.g., cystic fibrosis) where sputum samples are scarce due to modulator therapies.